The impact of COVID-19 on antidepressant sales and prescription dispensing in Australia.

Tscharke, Ben J; Hollingworth, Samantha; van Driel, Mieke L; O'Brien, Jake W; Thai, Phong K

Tscharke, Ben J; Hollingworth, Samantha; van Driel, Mieke L; O'Brien, Jake W; Thai, Phong K.

Tscharke BJ; Queensland Alliance for Environmental Health Sciences, The University of Queensland, Woolloongabba, QLD, Australia.
Hollingworth S; School of Pharmacy, The University of Queensland, Woolloongabba, QLD, Australia.
van Driel ML; Primary Care Clinical Unit, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
O'Brien JW; Queensland Alliance for Environmental Health Sciences, The University of Queensland, Woolloongabba, QLD, Australia.
Thai PK; Queensland Alliance for Environmental Health Sciences, The University of Queensland, Woolloongabba, QLD, Australia.

Aust N Z J Psychiatry ; 56(7): 871-872, 2022 07.

Article in English | MEDLINE | ID: covidwho-1582782

Subject(s)

COVID-19; Antidepressive Agents/therapeutic use; Australia/epidemiology; Drug Prescriptions; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study Limits: Humans Country/Region as subject: Oceania Language: English Journal: Aust N Z J Psychiatry Year: 2022 Document Type: Article Affiliation country: 00048674211068396

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google